Delivery Order SPE2DB22D2009-SPE2DB24FM1YA
Award Date
9/10/24
Potential Completion Date
9/11/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,015.22 Firm Fixed Price contract is for the delivery of 4,560,862,883 units of Methotrexate 2.5 mg tablets. The contract has an ultimate completion date of May 9, 2023 and is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,563.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of 4,565,634,382 units of Methotrexate 2.5 mg tablets. The contract has a completion date of August 30, 2024 and is a Firm Fixed Price Delivery Order. This contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Methotrexate 2.5 mg tablets in 100-count bottles, with a ceiling value of $4,588.56 and a completion date of September 3, 2024. The contract is a firm fixed-price delivery order, without any set-aside designation. As a large pharmaceutical supplier to the federal government, AmerisourceBergen has been awarded...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methotrexate 2.5 mg tablets in units of 20, with a ceiling value of $2,881.43 and a completion date of June 13, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Methotrexate 2.5 mg tablets, a medication used to treat various conditions. The contract has a ceiling value of $25,727.25 and an ultimate completion date of December 4, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award, with ID SPE2DB22D2009|SPE2DB25FL8VR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania. The contract is for the delivery of Methotrexate 2.5 mg tablets, a medication used to treat various conditions, and has a ceiling value of $3,779.10. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 17, 2025. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,685.34 Firm Fixed Price delivery order is for the supply of Methotrexate 2.5 mg tablets. The contract has an ultimate completion date of May 28, 2024 and was awarded on May 24, 2024. This appears to be a part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of 4,565,470,746 Methotrexate 2.5 mg tablets in 100-count bottles. The contract has a ceiling value of $2,867.85 and is a Firm Fixed Price Delivery Order with an ultimate completion date of August 16, 2024. The contract was awarded on August 15, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $8,967.93 firm-fixed-price contract is for the supply of Methotrexate 2.5 mg tablets. It has an ultimate completion date of August 21, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to federal agencies, including the military. This award is under a larger Indefinite Delivery...
This federal contract award is a delivery order valued at $6,361.41 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of methotrexate 2.5 mg tablets and has a completion date of November 5, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...